A similar study on BRAFV600E inhibitor-addicted melanoma cells revealed downregulation of MCM2, MCM3 and MCM5 upon drug withdrawal in correlation with reduced cell viability ensuing from discontinued drug treatment [33]. Here, MCM2 is linked to melanoma.